Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.71
Delayed Data
As of Jun 23
 -0.02 / -0.35%
Today’s Change
3.50
Today|||52-Week Range
8.85
-1.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues4.4M5.5M4.5M4.0M
 
 
 
 
 
Cost of Goods Sold1.1M1.2M709.7K659.6K
 
 
 
 
 
Depreciation And Amortization24.3K40.5K48.1K49.7K
 
 
 
 
 
 
Operating ExpensesGross Income3.2M4.3M3.7M3.3M
 
 
 
 
 
General Expenses24.5M29.4M26.7M24.6M
 
 
 
 
 
Research And Development13.8M14.7M10.3M7.7M
 
 
 
 
 
Total Operating Expenses25.6M30.7M27.4M25.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.2M-25.1M-22.9M-21.3M
 
 
 
 
 
Other Expenses0.00109.9K101.4K126.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.1M-25.0M-22.8M-21.2M
 
 
 
 
 
Net Income-21.1M-25.0M-22.8M-21.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS196.3M196.5M196.6M197.8M
 
 
 
 
 
Shares To Calculate EPS Diluted196.3M196.5M196.6M197.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.13-$0.12-$0.11
 
 
 
 
 
EPS Diluted-$0.11-$0.13-$0.12-$0.11